Navigation Links
Inserm announces the recipients of its 2012 prizes
Date:12/4/2012

This press release is available in French.

The 2012 Inserm prizes for medical research will be awarded at a ceremony at the Collge de France on Monday 3 December 2012. This year, the grand prize will be awarded to Philippe Sansonetti in the presence of Marisol Touraine, France's Minister of Social Affairs and Health, Genevive Fioraso, France's Minister of Higher Education and Research, and Professor Andr Syrota, Chairman and CEO of Inserm. The grand prize is awarded each year to honour a member of the scientific research community whose work has contributed to advancing knowledge of human physiology, therapeutics and health in general.

Inserm Grand Prize Philippe Sansonetti

The recipient of the 2012 Grand Prize is Professor Philippe Sansonetti, the director of the Microbial Colonisation and Invasion of Mucosa unit (Inserm Unit 786) at the Institut Pasteur in Paris, in recognition of his research on microbial infection.

Prof. Sansonetti was the first to update the genetic bases in bacteria, particularly in Shigella, which causes dysentery, and which he studied the entire sequence of steps that are required for infection.

Prof. Sansonetti coordinates, along with Pascale Cossart, the Integrative Biology of Emerging Infectious Diseases laboratory of excellence.

International Prize Ingrid Grummt

The recipient of Inserm's International Prize is Professor Ingrid Grummt of the German Cancer Research Centre of Heidelberg in recognition of her epigenetics research on the molecular mechanisms that regulate gene expression.

Honour Prize Jean-Paul Soulillou

The recipient of Inserm's Honour Prize is Professor Jean-Paul Soulillou, who heads Inserm's Lymphocyte Regulation and Tolerance team at the Centre for Transplantation and Immunology Research (Inserm Unit 1064) in Nantes, France, in recognition of his work on transplant tolerance.

Prof. Soulillou is notably behind the development of a "smart" antibody that is widely used to prevent transplant rejection and his research interests include the development of highly effective immunosuppressants.

Research Prizes Sophie Ugolini and Jessica Zucman-Rossi

The Research Prizes are awarded to:

- Sophie Ugolini, an Inserm research director at the Marseille-Luminy Immunology Centre, for her work on the function of natural killer cells (NK cells).

- Jessica Zucman-Rossi, director of the Functional Genomics of Solid Tumours unit in Paris (Inserm Unit 674), for her work on the identification and understanding of the role of gene interactions in human tumours, particularly the Ewing family of tumours.

Innovation Prize Alain de Cesare and Marc Lopez

The Innovation Prizes are awarded to two engineers in recognition of their support in guiding research:

- Alain de Cesare, an Inserm research engineer at the Functional Imaging Laboratory (Inserm Unit 678) in Paris and a designer of medical imaging analysis software.

- Marc Lopez, an Inserm research engineer at the Marseille Oncology Research Centre (Inserm Unit 1068) who identified the cellular adhesion molecules known as nectins.


'/>"/>
Contact: Inserm press office
presse@inserm.fr
INSERM (Institut national de la sant et de la recherche mdicale)
Source:Eurekalert

Related medicine news :

1. EPSRC announces new green engineering projects
2. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces Faster Weight Loss than a "No-Diet" Weight Loss Diet
3. Gabrielles Angel Foundation for Cancer Research announces 2 collaborative research grants
4. Feinstein announces submission of new drug application for diagnosing parkinsonian syndromes
5. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
6. Plastic and Reconstructive Surgery Journal announces global expansion initiatives
7. NY-Presbyterian Hospital announces participation in trial for hard-to-treat hypertension
8. Northeasterns Barnett Institute announces formation of leading analytics company, BioAnalytix, LLC
9. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
10. CRF announces late breaking trials and first report investigations to be presented at TCT 2012
11. SfN announces winners of brain awareness video contest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... to 2022" report to their offering. ... financial data derived from varied research sources to present unique ... on the market during the next five years, including a ... markets, regional and country level analysis. The report provides a ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
Breaking Medicine Technology: